cimetidine has been researched along with Dermatitis, Atopic in 4 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, TK | 1 |
| Man, MQ | 1 |
| Santiago, JL | 1 |
| Park, K | 1 |
| Roelandt, T | 1 |
| Oda, Y | 1 |
| Hupe, M | 1 |
| Crumrine, D | 1 |
| Lee, HJ | 1 |
| Gschwandtner, M | 1 |
| Thyssen, JP | 1 |
| Trullas, C | 1 |
| Tschachler, E | 1 |
| Feingold, KR | 1 |
| Elias, PM | 1 |
| Deutsch, PH | 1 |
| Frosch, PJ | 1 |
| Schwanitz, HJ | 1 |
| Macher, E | 1 |
| Foulds, IS | 1 |
| MacKie, RM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Skin Barrier Dysfunction and the Role of Skin Barrier Restoration on Cutaneous and Systemic Inflammation in the Aged Population[NCT03728569] | Early Phase 1 | 14 participants (Actual) | Interventional | 2018-05-16 | Terminated (stopped due to Enrollment and interactions/interventions paused due to COVID-19. Not expected to resume in the future. This is not a suspension of IRB approval) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for cimetidine and Dermatitis, Atopic
| Article | Year |
|---|---|
A double blind trial of H1 and H2 receptor antagonists in the treatment of atopic dermatitis.
Topics: Adolescent; Adult; Chlorpheniramine; Cimetidine; Clinical Trials as Topic; Dermatitis, Atopic; Doubl | 1984 |
A double-blind trial of the H2 receptor antagonist cimetidine, and the H1 receptor antagonist promethazine hydrochloride in the treatment of atopic dermatitis.
Topics: Adolescent; Adult; Cimetidine; Clinical Trials as Topic; Dermatitis, Atopic; Double-Blind Method; Fe | 1981 |
2 other studies available for cimetidine and Dermatitis, Atopic
| Article | Year |
|---|---|
Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function.
Topics: Administration, Topical; Animals; Cell Differentiation; Cimetidine; Dermatitis, Atopic; Dermatitis, | 2013 |
Dermatographism treated with hydroxyzine and cimetidine and ranitidine.
Topics: Adult; Cimetidine; Dermatitis, Atopic; Drug Therapy, Combination; Humans; Hydroxyzine; Male; Pruritu | 1984 |